Sept 24 (Reuters) - Swedencare AB (publ) SECARE.ST :
* SAYS WILL CARRY OUT A DIRECTED NEW SHARE ISSUE OF
APPROXIMATELY
SEK 300 MILLION TO SWEDISH AND INTERNATIONAL INSTITUTIONAL
INVESTORS
* SAYS SHARE ISSUE IS CARRIED OUT AS PART OF FINANCING OF
ACQUISITIONS OF UK ANIMAL HEALTH COMPANY NUTRAVET (UK) LIMITED
AND OPERATIONS CONDUCTED BY AMERICAN ANIMAL HEALTH COMPANY
ANIMAL PHARMACEUTICALS INC. ( "ACQUISITIONS"), AS ANNOUNCED BY
COMPANY EARLIER TODAY.
* SAYS SHARE ISSUE IS INTENDED TO BE CARRIED OUT WITH
DEVIATION
FROM SHAREHOLDERS' PREFERENTIAL RIGHTS AND WITH SUPPORT OF
AUTHORIZATION GRANTED BY EXTRA GENERAL MEETING HELD ON SEPTEMBER
11, 2020.
* SAYS RATIONALE FOR CARRYING OUT DIRECTED NEW SHARE ISSUE
AND FOR
DEVIATION FROM SHAREHOLDERS' PREFERENTIAL RIGHTS IS TO SECURE
FINANCING IN A TIME- AND COST-EFFECTIVE MANNER FOR ACQUISITIONS
Source text for Eikon: ID:nWkr56PHDJ
Further company coverage: SECARE.ST
(Reporting by Colm Fulton)
((Colm.Fulton@thomsonreuters.com;))